Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PI 42:9)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003814 AN006272 Sulfur Amino Acid Restriction Enhances Exercise Capacity in Mice by Boosting Fat Oxidation in Muscle - extensor digitorum longus (EDL) versus soleus (Sol) on Con and SAAR diet lipidomics Muscle Mouse Princeton University LC-MS
ST003038 AN004984 Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. Liver Mouse Diabetes Vanderbilt University Medical Center LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
ST001988 AN003240 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 2) LNCaP cells Human Cancer IGMM LC-MS
ST001359 AN002263 Monophasic lipidomics extraction in cancer cell line Hep G2 cells Human Cancer Beatson Institute for Cancer Research LC-MS
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST000110 AN000184 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo